MRC Centre for Molecular Bacteriology and Infection, Imperial College London, Armstrong Road, London SW7 2AZ, UK.
Present address: Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Microbiology (Reading). 2023 Jan;169(1). doi: 10.1099/mic.0.001292.
The type three secretion system injectisome of Gram-negative bacterial pathogens injects virulence proteins, called effectors, into host cells. Effectors of mammalian pathogens carry out a range of functions enabling bacterial invasion, replication, immune suppression and transmission. The injectisome secretes two translocon proteins that insert into host cell membranes to form a translocon pore, through which effectors are delivered. A subset of effectors also integrate into infected cell membranes, enabling a unique range of biochemical functions. Both translocon proteins and transmembrane effectors avoid cytoplasmic aggregation and integration into the bacterial inner membrane. Translocated transmembrane effectors locate and integrate into the appropriate host membrane. In this review, we focus on transmembrane translocon proteins and effectors of bacterial pathogens of mammals. We discuss what is known about the mechanisms underlying their membrane integration, as well as the functions conferred by the position of injectisome effectors within membranes.
革兰氏阴性细菌病原体的 III 型分泌系统注射器将毒力蛋白(称为效应子)注入宿主细胞。哺乳动物病原体的效应子执行一系列功能,使细菌能够入侵、复制、免疫抑制和传播。注射器分泌两种易位子蛋白,插入宿主细胞膜形成易位子孔,通过该孔输送效应子。一部分效应子也整合到感染的细胞膜中,从而实现独特的一系列生化功能。两种易位子蛋白和跨膜效应子都避免了细胞质聚集和整合到细菌内膜中。易位的跨膜效应子定位并整合到适当的宿主膜中。在这篇综述中,我们重点介绍哺乳动物细菌病原体的跨膜易位子蛋白和效应子。我们讨论了关于它们膜整合机制的已知内容,以及注射器效应子在膜内位置赋予的功能。